Want to see INGN full AI Analyst Report?
INGN Stock Chart & Stats
$6.15
-$0.17(-2.69%)
At close: 4:00 PM EDT
$6.15
-$0.17(-2.69%)
Day’s Range― - ―
52-Week Range$5.34 - $9.13
Previous CloseN/A
Volume233.40K
Average Volume (3M)387.79K
Market Cap
$159.76M
Enterprise Value$83.39
Total Cash (Recent Filing)$105.54M
Total Debt (Recent Filing)$15.79M
Price to Earnings (P/E)―
Beta1.01
Next Earnings
Nov 11, 2026EPS Estimate
-0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.90
Shares Outstanding26,538,338
10 Day Avg. Volume310,281
30 Day Avg. Volume387,791
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)0.95
Price to Sales (P/S)0.52
P/FCF Ratio-8.46
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$13.00Price Target Upside111.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.78
Revenue Forecast (FY)$369.13M
Bulls Say, Bears Say
Bulls Say
International GrowthSustained double-digit international growth across ten consecutive quarters indicates durable geographic diversification. This reduces dependence on U.S. channels, expands addressable markets, and supports steadier revenue streams as local reimbursements and distributor channels mature over multiple quarters.
Improving Margins & Profitability TrajectoryMargin expansion and rising adjusted EBITDA show the business is gaining operating leverage from mix, pricing, and cost control. If sustained, improved margins enable reinvestment in R&D and commercialization of new products (Voxi/Aurora), supporting longer-term earnings durability beyond one-off gains.
Strong Liquidity & Low LeverageA sizable cash balance and no debt provide financial flexibility to fund trials, product rollouts, and international expansion without immediate refinancing risk. Positive quarterly cash generation supports operational resilience while management executes strategic initiatives over the next several quarters.
Bears Say
Persistent Losses & Cash InconsistencyDespite revenue and margin improvements, multi‑period negative operating profits and persistent negative free cash flow signal the company hasn’t yet achieved self-sustaining cash generation. Continued losses erode equity and raise execution risk if improved profitability does not persist.
U.S. DTC Channel WeaknessA structural decline in the direct‑to‑consumer U.S. channel reduces higher‑margin direct sales and increases reliance on slower B2B adoption. Prolonged DTC weakness can compress unit economics, slow revenue recovery, and require greater marketing or channel investment to regain share.
Rental Revenue Structural DeclineA 12% decline in rental revenue reflects HMEs prescribing POCs earlier and a shrinking rental funnel. Rentals historically provided recurring revenue and drove installed base accessory demand; ongoing rental declines reduce predictable recurring cash flows and weaken long‑term customer lifetime value.
Inogen News
INGN FAQ
What was Inogen’s price range in the past 12 months?
Inogen lowest stock price was $5.34 and its highest was $9.13 in the past 12 months.
What is Inogen’s market cap?
Inogen’s market cap is $159.76M.
When is Inogen’s upcoming earnings report date?
Inogen’s upcoming earnings report date is Nov 11, 2026 which is in 91 days.
How were Inogen’s earnings last quarter?
Inogen released its earnings results on Aug 06, 2026. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.153 by $0.013.
Is Inogen overvalued?
According to Wall Street analysts Inogen’s price is currently Undervalued.
Does Inogen pay dividends?
Inogen does not currently pay dividends.
What is Inogen’s EPS estimate?
Inogen’s EPS estimate is -0.11.
How many shares outstanding does Inogen have?
Inogen has 26,538,338 shares outstanding.
What happened to Inogen’s price movement after its last earnings report?
Inogen reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.153. Following the earnings report the stock price went down -6.78%.
Which hedge fund is a major shareholder of Inogen?
Currently, no hedge funds are holding shares in INGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Inogen Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.00 (111.38% Upside)
$13.00 (111.38% Upside)
Blogger Sentiment
Bullish
INGN Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 469.6K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.54%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-8.48%
Trailing 12-Months
Company Description
Inogen
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
INGN Company Deck
INGN Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call highlighted clear commercial and product progress — notably strong international revenue growth (+15% YoY), continued POC unit expansion (>12% YoY), early traction for new products (Voxi shipments >5,000; Aurora account count doubled), margin improvement (adjusted gross margin +65 bps) and a raised adjusted EBITDA outlook. Offsetting these positives are ongoing headwinds in the U.S. DTC channel (U.S. sales -2% YoY), a 12% decline in rental revenue, a downward revision to full-year revenue guidance (midpoint reduction of ~ $11.5M), and continued dependency on distributor purchase timing and reimbursement/regulatory milestones. Overall the company shows momentum in strategic growth areas and improved unit economics, but macro and channel mix pressures keep near-term top-line growth constrained.View all INGN earnings summariesINGN Stock 12 Month Forecast
Average Price Target
$13.00
▲(111.38% Upside)
Technical Analysis
Ownership Overview
3.65% Insiders
16.96% Mutual Funds
3.04% Other Institutional Investors
65.98% Public Companies and
Individual Investors